Skin cancer associated with calcineurin inhibitors treatment: analysis of FAERS database
Our study has provided new real-world evidence regarding the safety of CNIs concerning skin cancers. It is recommended that clinicians remain vigilant about CNI-associated skin cancers and implement early surveillance to prevent adverse outcomes.
Authors
- Zhuoling An (ORCID: https://orcid.org/0009-0005-1162-4227)
- Yuezhen Zhu (ORCID: https://orcid.org/0000-0002-3730-402X)
- Hui Yang (ORCID: https://orcid.org/0000-0002-1797-2215)
Institutions
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Schlumberger (Ireland) (IE)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1080/14740338.2024.2443783
- Citations
- 2
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77